The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1225
Bid: 0.12
Ask: 0.125
Change: 0.00 (0.00%)
Spread: 0.005 (4.167%)
Open: 0.1225
High: 0.1225
Low: 0.1225
Prev. Close: 0.1225
SYN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer Closed for Acceptance

12 Nov 2019 07:00

RNS Number : 0372T
Camelot Capital Partners LLC
12 November 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

RECOMMENDED CASH OFFER 

FOR

SYNNOVIA PLC ("Synnovia")

BY

BPF1 LIMITED ("BIDCO"), A WHOLLY-OWNED SUBSIDIARY OF FUNDS ADVISED BY CAMELOT CAPITAL PARTNERS LLC

OFFER CLOSED FOR ACCEPTANCE

On 3 September 2019, the Bidco Director and the Independent Synnovia Directors announced the terms of a recommended offer to be made by Bidco for the entire issued and to be issued share capital of Synnovia, pursuant to Rule 2.7 of the Takeover Code (the "Offer"). The full terms and conditions of the Offer, together with the procedures for acceptance of the Offer, were set out in the offer document issued by Synnovia on 23 September 2019 (the "Offer Document") and, in respect of certificated Synnovia Shares, the accompanying Form of Acceptance. On 11 October 2019 Synnovia announced the results of the General Meeting, which included the approval of the Management Shareholder Resolution, a key condition to the Offer.

On 29 October 2019, Bidco announced that it had decided to waive the acceptance condition under the Offer and that the Offer was unconditional as to acceptances and wholly unconditional.

On 29 October 2019, Synnovia announced that it had informed the London Stock Exchange that it wished to cancel the admission to trading of the Synnovia Shares on AIM (the "Cancellation"). Cancellation is expected to take effect from 7:00am on 26 November 2019, being 20 business days from the date of the announcement.

Following Cancellation, Bidco will seek to re-register Synnovia as a private limited company.

Capitalised terms used in this announcement, unless otherwise defined, have the same meanings as set out in the Offer Document.

No extension to the Offer

The Offer was open for acceptance until 1:00pm (London time) on 11 November 2019. The Offer has now closed and is no longer capable of being accepted.

Level of acceptances

As at 1:00pm (London time) on 11 November 2019 Bidco had received valid acceptances of the Offer in respect of a total of 21,221,574 Synnovia Shares, representing approximately 54.4 per cent. of Synnovia's existing issued share capital, and 94.2 per cent. of the Synnovia shares to which the Offer relates. This includes acceptances for a total of 6,213,500 Synnovia Shares, representing approximately 15.9 per cent. of Synnovia's existing issued share capital in relation to irrevocable undertakings given by the Independent Synnovia Directors, certain other Synnovia Shareholders and Faisal Rahmatallah's (who is considered to be acting in concert with Bidco) FR SIPP shares.

Bidco's parent Company holds 11,659,513 Synnovia Shares and it has agreed to transfer those shares to Bidco along with the Management Shareholders who have agreed to transfer an additional 4,804,855 Synnovia Shares to Bidco pursuant to the Management Share Exchange Agreement, representing approximately in aggregate 42.2 per cent. of Synnovia's entire issued share capital. Accordingly, as at 1:00pm (London time) on 11 November 2019, Bidco owned or will own pursuant to the Management Share Exchange Agreement or had received valid acceptances in respect of a total of 37,685,942 Synnovia Shares, representing approximately 96.6 per cent. of Synnovia's entire issued share capital.

The percentages listed in this announcement are based on a current issued share capital of 38,995,151 Synnovia Shares.

Compulsory acquisition

As Bidco has now received acceptances in respect of, and/or otherwise acquired, 90 per cent. or more of the Synnovia Shares by nominal value and voting rights attaching to such shares to which the Offer relates, Bidco intends to exercise its rights pursuant to the provisions of Chapter 3 of Part 28 of the Companies Act to compulsorily acquire the remaining Synnovia Shares in respect of which the Offer has not been accepted on the same terms as the Offer.

Settlement of the consideration

Settlement of the consideration to which any accepting Synnovia Shareholder is entitled under the Offer will be despatched as follows: in the case of acceptances which had been received by 1pm on 11 November 2019 and are valid and complete in all respects, within 14 calendar days of such receipt, in each case in the manner described in the Offer Document.

Interests in Synnovia Shares

As at the close of business on 11 November 2019, being the latest practicable date prior to publication of this announcement, the interests of Bidco and its concert parties and their immediate families, related trusts and connected persons, all of which are beneficial unless otherwise stated, in relevant securities were as follows:

Name

Type of relevant security held

Number of relevant securities

Approximate aggregate percentage of the existing issued share capital, and voting rights, of Synnovia

Bidco

Synnovia Shares

11,659,513

29.9

Faisal Rahmatallah

Synnovia Shares

2,761,669(1)(2)(3)(4)

6.8

Richard Vessey

Synnovia Shares

2,591,865

6.6

Nicholas Ball

Synnovia Shares

266,820

0.7

 

(1) 1,946,170 of the Synnovia Shares in which Faisal Rahmatallah has an interest are registered in the name of Nicolino Assets Holdings Limited

(2)202,434 of the Synnovia Shares in which Faisal Rahmatallah has an interest are registered in the name of Lawshare Nominees Limited as the nominee of Faisal Rahmatallah's self-invested personal pension provider

(3)512,463 of the Synnovia Shares in which Faisal Rahmatallah has an interest are registered in the name of R&H Trust Co (Jersey) Limited

(4)100,602 of the Synnovia Shares in which Faisal Rahmatallah has an interest are registered in the name of Lawshare Nominees Limited as the nominee of the self-invested personal pension provider of Jane Margaret O'Riordan, a connected person of Faisal Rahmatallah

With the exception of the interests set out above, as at close of business on 11 November 2019, being the latest practicable date prior to publication of this announcement, neither Bidco, nor any person acting in concert with it for the purposes of the Offer, is interested in or has any rights to subscribe for any Synnovia Shares, nor does any such person have any short position (whether conditional or absolute and whether in the money or otherwise), including any short position under a derivative or any arrangement in relation to any relevant securities of Synnovia. For these purposes 'arrangement' includes any agreement to sell or any dealing obligation or right to require another person to purchase or take delivery of any relevant securities of Synnovia, and any borrowing or lending of any relevant securities of Synnovia which have not been on-lent or sold and any outstanding irrevocable commitment or letter of intent with respect to any relevant securities of Synnovia.

Enquiries:

Synnovia

 

Nick Ball (Group Finance Director)

Tel: 020 7978 0574

 

 

Numis Securities Limited (financial adviser to Bidco)

Tel: 020 7260 1000

Stuart Ord

 

George Fry

 

Jono Mawson

 

 

 

Cenkos Securities plc (financial adviser and nominated adviser to Synnovia)

 

Stephen Keys

Tel: 020 7397 8900

Callum Davidson

 

Important Information

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as financial adviser to Bidco and no one else in connection with the Offer and other matters referred to in this announcement. In connection with these matters, Numis, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to anyone other than Bidco for providing the protections afforded to the clients of Numis nor for providing advice in relation to the matters referred to in this announcement.

Cenkos Securities plc ("Cenkos"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as financial adviser to Synnovia and no-one else in connection with the Offer and other matters referred to in this announcement. In connection with these matters, Cenkos, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to anyone other than Synnovia for providing the protections afforded to the clients of Cenkos nor for providing advice in relation to the matters referred to in this announcement.

Further information

This announcement is not intended to, and does not, constitute, or form part of, any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Offer or otherwise. The Offer is being made solely by means of the Offer Document and the Form of Acceptance accompanying the Offer Document, which contains the full terms of, and Conditions to, the Offer, including details of how the Offer may be accepted. Any response to the Offer should be made only on the basis of information contained in the Offer Document. Synnovia Shareholders are advised to read the formal documentation in relation to the Offer carefully.

This announcement has been prepared for the purposes of complying with English law, the AIM Rules and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside the United Kingdom.

Overseas jurisdictions

The distribution of this announcement in jurisdictions other than the United Kingdom and the ability of Synnovia Shareholders who are not resident in the United Kingdom to participate in the Offer may be affected by the laws of relevant jurisdictions. Therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom or Synnovia Shareholders who are not resident in the United Kingdom will need to inform themselves about, and observe, any applicable legal or regulatory requirements. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. Further details in relation to overseas Synnovia Shareholders is contained in the Offer Document.

The Offer is not being, and will not be, made available, directly or indirectly, in or into or by the use of the mails of, or by any other means or instrumentality of interstate or foreign commerce of, or any facility of a national state or other securities exchange of, any Restricted Jurisdiction unless conducted pursuant to an exemption from the applicable securities laws of such Restricted Jurisdiction.

Accordingly, copies of this announcement and all documents relating to the Offer are not being, and must not be, directly or indirectly, mailed, transmitted or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction except pursuant to an exemption from the applicable securities laws of such Restricted Jurisdiction and persons receiving this announcement (including, without limitation, agents, nominees, custodians and trustees) must not distribute, send or mail it in, into or from such jurisdiction. Any person (including, without limitation, any agent, nominee, custodian or trustee) who has a contractual or legal obligation, or may otherwise intend, to forward this announcement and/or the Offer Document and/or any other related document to a jurisdiction outside the United Kingdom should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdiction.

Information relating to Synnovia Shareholders

Please be aware that addresses, electronic addresses and certain other information provided by Synnovia Shareholders, persons with information rights and other relevant persons for the receipt of communications from Synnovia may be provided to Bidco during the Offer Period as required under Section 4 of Appendix 4 to the Takeover Code.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPZMMMMRMKGLZM
Date   Source Headline
19th Feb 20197:00 amRNSTrading Statement
20th Dec 20184:37 pmRNSDirector/PDMR Shareholding
20th Dec 201811:35 amRNSResult of General Meeting and Change of Name
20th Dec 20187:00 amRNSDirector/PDMR Shareholding
14th Dec 20182:23 pmRNSDirector/PDMR Shareholding
14th Dec 201810:35 amRNSDirector/PDMR Shareholding
5th Dec 20186:27 pmRNSDirector/PDMR Shareholding
5th Dec 201810:16 amRNSHolding(s) in Company
5th Dec 201810:12 amRNSHolding(s) in Company
3rd Dec 20187:00 amRNSHalf-year Report
16th Nov 201811:01 amRNSNotice of Results
5th Oct 20188:00 amRNSTrading Statement
28th Aug 20188:36 amRNSHolding(s) in Company
30th Jul 20182:36 pmRNSResult of AGM
25th Jul 20181:54 pmRNSDirector/PDMR Shareholding
16th Jul 20188:13 amRNSDirector/PDMR Shareholding
9th Jul 20181:46 pmRNSAnnual Financial Report
2nd Jul 20187:00 amRNSFinal Results
22nd Jun 20187:00 amRNSNotice of Results
2nd May 20187:00 amRNSTrading Update
11th Apr 201811:02 amRNSUK Investor Show
16th Mar 20182:22 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTrading Statement
6th Dec 20177:00 amRNSHalf-year Report
20th Nov 20179:38 amRNSNotice of Results
17th Nov 201710:54 amRNSHolding(s) in Company
5th Oct 20173:48 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:43 pmRNSDirector/PDMR Dealing and Issue of Equity
2nd Oct 20177:00 amRNSTrading Update
1st Aug 20173:42 pmRNSResult of AGM
12th Jul 201711:32 amRNSHolding(s) in Company
11th Jul 20179:19 amRNSHolding(s) in Company
7th Jul 20174:41 pmRNSAnnual Financial Report
3rd Jul 20177:00 amRNSFinal Results
12th Jun 20177:00 amRNSNotice of Results
8th Jun 20175:06 pmRNSHolding(s) in Company
5th Jun 20179:32 amRNSHolding(s) in Company
1st Jun 20174:28 pmRNSApplication for Admission
26th May 20177:00 amRNSPlacing to raise £3.74 million
2nd May 20177:00 amRNSTrading Update
23rd Mar 20178:37 amRNSHolding(s) in Company
27th Feb 20177:00 amRNSPresentation at ShareSoc Growth Company Seminar
20th Feb 20171:30 pmRNSDirector/PDMR Shareholding
13th Feb 20177:00 amRNSTrading Update
30th Jan 20173:45 pmRNSIssue of Equity and Directors' Shareholdings
20th Jan 201711:43 amRNSResult of Scrip Dividend Alternative
12th Jan 20177:00 amRNSGrowth & Innovation Forum
11th Jan 20172:38 pmRNSDirector/PDMR Shareholding
29th Dec 201610:15 amRNSScrip Dividend Reference Price
5th Dec 20167:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.